Related Experiment Video

Updated: Jun 3, 2026

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
06:57

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

Airway microbiology and host defences in paediatric non-CF bronchiectasis

Keith Grimwood1

  • 1Queensland Paediatric Infectious Diseases Laboratory, Queensland Children's Medical Research Institute, The University of Queensland, Royal Children's Hospital, Brisbane, Queensland, Australia. k.grimwood@uq.edu.au

Paediatric Respiratory Reviews
|April 5, 2011
PubMed

Insights

Pediatric bronchiectasis without cystic fibrosis stems from recurrent pneumonia and immune defects, creating a cycle of inflammation and lung injury. Identifying pathogens like Haemophilus influenzae is key for managing this complex childhood respiratory condition.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Immunology

Background:

  • Bronchiectasis in children, excluding cystic fibrosis cases, disproportionately affects socioeconomically disadvantaged populations.
  • Recurrent childhood pneumonia and compromised pulmonary defenses initiate a detrimental cycle of impaired mucociliary clearance, infection, airway inflammation, and progressive lung damage.
  • This complex respiratory disorder arises from susceptibility to infections and dysregulated innate and adaptive immunity, leading to persistent, excessive airway inflammation even after infection resolution.

Purpose of the Study:

  • To elucidate the risk factors, pathogens, and underlying mechanisms of bronchiectasis in children without cystic fibrosis.
  • To understand the 'vicious cycle' involving impaired mucociliary clearance, infection, inflammation, and lung injury.
  • To highlight the need for improved diagnostic methods for this condition.

Main Methods:

  • Review of existing literature on pediatric bronchiectasis pathogenesis and microbiology.
  • Analysis of common etiological agents and risk factors, including socioeconomic status and early childhood infections.
  • Discussion of immunological aspects and inflammatory responses in the affected airways.

Main Results:

  • Key risk factors include recurrent early childhood pneumonia and defective pulmonary defenses.
  • Common pathogens identified are Haemophilus influenzae (predominant), Streptococcus pneumoniae, Moraxella catarrhalis, and Pseudomonas aeruginosa (in older children).
  • The role of viruses and upper airway commensal bacteria remains uncertain, with limitations in microbiological data and specimen collection from young children.

Conclusions:

  • Bronchiectasis in children without cystic fibrosis is a multifactorial condition driven by infection susceptibility and aberrant immune responses.
  • Persistent airway inflammation, even post-infection, characterizes the disease.
  • Advancements in specimen collection, molecular techniques, and biomarkers are crucial for improving diagnosis and management.

More Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...